Health News Archive - May 15, 2009
Reaches severance agreement with unions SEATTLE, May 15 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc.
Doctors, who diagnose some 1 in 5 heart problems before symptoms appear, are missing opportunities to identity heart disease early, U.S.
SEATTLE, May 15 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc.
MUNICH, May 15 /PRNewswire/ -- - Investigating the Real Burden of Hypertension, Addressing the Challenges of Getting to Blood Pressure Goal and SHARE(ing) the Knowledge (http://www.SHARE-hypertension.com) The SHARE steering committee announce the launch of Supporting Hypertension Awareness & Research Europe-wide (SHARE) program on World Hypertension Day 2009 (17th May).
HAIKOU CITY, China, May 15 /PRNewswire-Asia-FirstCall/ -- China Pharma Holdings, Inc.
BEIJING, May 15 /PRNewswire-Asia/ -- Sinovac Biotech Ltd.
IRVINE, Calif., May 15 /PRNewswire-FirstCall/ -- Endocare, Inc.
WEIFANG, Shandong, China, May 15 /PRNewswire-Asia-FirstCall/ -- Shengtai Pharmaceutical, Inc.
Test results to establish Group B Strep colonization of pregnant women and help clinicians guide antibiotic therapy to prevent infections in newborns GBS PNA FISH shown to detect up to 42% more positive results than conventional culture methods (1) WOBURN, Mass.
Cimzia(R) (certolizumab pegol) now offered in an innovative prefilled syringe designed in partnership with OXO GOOD GRIPS(R) ATLANTA, May 15 /PRNewswire/ --- UCB today announced that Cimzia(R) (certolizumab pegol), the only PEGylated anti-TNF (Tumor Necrosis Factor) approved in the U.S.
- An uxorious, effeminate, or spiritless man.
- A timorous, cowardly fellow.